All News about Glaukos Corp
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
February 27, 2023
From Glaukos Corporation
Via Business Wire
Via Benzinga
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From Glaukos Corporation
Via Business Wire
Earnings Preview For Glaukos
February 21, 2023
Via Benzinga
Analyst Expectations for Glaukos's Future
December 28, 2022
Via Benzinga
10 Analysts Have This to Say About Glaukos
December 28, 2022
Via Benzinga
What 10 Analyst Ratings Have To Say About Glaukos
December 28, 2022
Via Benzinga
7 Analysts Have This to Say About Glaukos
December 12, 2022
Via Benzinga
Analyst Ratings for Glaukos
December 12, 2022
Via Benzinga
Glaukos Announces Participation in the Citi Healthcare Conference
February 15, 2023
From Glaukos Corporation
Via Business Wire
Where Glaukos Stands With Analysts
December 12, 2022
Via Benzinga
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 28, 2022
From Glaukos Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022
December 19, 2022
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
December 12, 2022
Via Benzinga
From Glaukos Corporation
Via Business Wire
Glaukos Corporation Announces Third Quarter 2022 Financial Results
November 02, 2022
From Glaukos Corporation
Via Business Wire
Important Biotech Catalysts For September 7, 2022 - End Of The Day Summary
September 07, 2022
Via Benzinga
Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday
September 08, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.